ALAN CRAWFORD: Open Payments
NPI 1720048002 · OCEAN SPRINGS, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,877 in 106 payments from 20 companies in 2025. Trend: 2023 $1,094 · 2024 $2,070 · 2025 $1,877
Food & beverage: $1,851Education: $25
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 12 | $323 |
| ABBVIE INC. | 24 | $284 |
| Lilly USA, LLC | 9 | $186 |
| GENZYME CORPORATION | 11 | $178 |
| Janssen Biotech, Inc. | 14 | $177 |
| Almirall LLC | 7 | $142 |
| Novartis Pharmaceuticals Corporation | 7 | $128 |
| Regeneron Healthcare Solutions, Inc. | 2 | $60 |
| Organon LLC | 2 | $57 |
| PFIZER INC. | 3 | $57 |
Products named: Bimzelx, DUPIXENT, TREMFYA, RINVOQ, COSENTYX, Klisyri, SKYRIZI, TALTZ.
Industry payments across MS — which companies pay providers there.
